Business Wire

Crayon redefines cloud performance with breakthrough processor technology

Share

Crayon, a global leader in IT services and innovation, today announced its continued collaboration with AMD to revolutionize cloud performance using AMD EPYC™ server processors. This collaboration enables businesses to unlock unprecedented levels of efficiency by optimizing the physical processors powering their cloud infrastructure, delivering both performance and cost savings beyond traditional virtualization.

“As a leader in cost optimization, FinOps, and software asset management (SAM), we've consistently focused on helping customers maximize the value of their technology investments while reducing costs,” said Gudmundur Adalsteinsson, Crayon’s Chief Revenue Officer.

“Our advanced FinOps practices ensure that organizations maintain financial accountability in cloud environments, providing real-time visibility and control over cloud spend across Azure, AWS, and GCP. This, combined with our collaboration with AMD, elevates our mission further. With the establishment of the Crayon Cloud Performance Lab, we ensure that our customers can fully leverage the most optimal processors and configurations, specifically tuned to their individual workloads, to enhance performance and reduce costs. AMD EPYC server processors deliver leadership performance for Enterprise, HPC, and AI workloads with advanced security features,” he continued.

Crayon has recently established its own Performance Lab, a dedicated unit tasked with conducting performance tests on different workloads using AMD EPYC server processors. The Lab utilizes standard test scripts and processes to validate test results and provide clients with detailed, accurate workload performance comparisons across various cloud providers and operating systems to determine optimal cloud configurations. The Lab's independent testing confirms the exceptional efficiency of AMD processors, offering clients a reliable assessment of potential cost savings and performance gains.

Rigorous testing by the Performance Lab has validated that AMD EPYC server processors deliver exceptional efficiency, helping reduce the power consumption needed for high-performance workloads. Businesses can save on their cloud compute estate by considering underlying physical processors and moving beyond a purely virtualized approach. This makes the Crayon-AMD collaboration especially relevant for organizations looking to reduce operational costs while maximizing the power of their cloud environments.

“The ability to harness the full potential of AMD EPYC server processors is a game-changer for businesses aiming to reduce energy consumption and increase performance,” said Blaine Noel, Sr. Director, at AMD. “By optimizing cloud compute resources, combined with a traditional on-premise deployment model, companies can achieve significant cost savings and modernize their infrastructure.”

This collaboration marks a critical step in the evolution of cloud computing, providing businesses with the tools they need to stay ahead in a fast-changing landscape. As workloads become increasingly complex, Crayon and AMD are leading the charge in helping ensure cloud environments are ready to meet those demands efficiently.

AMD, the AMD Arrow logo, EPYC, and combinations thereof are trademarks of Advanced Micro Devices, Inc.

About Crayon

Headquartered in Oslo, Norway, with a global presence spanning 46 countries and a dedicated team of 4,000 professionals, Crayon champions IT optimization and innovation. We are a customer-first company providing return on investment on software and cloud spend by empowering our customers to strategically acquire and optimize software investments, embrace cloud and AI technologies, and drive innovation through enhanced efficiency.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240930779641/en/

Contacts

Linda Rønningen
Email: linda.ronningen@crayon.com

+47 405 55 278

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release

Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i

Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release

Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d

The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release

Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it

4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release

4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B

Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release

Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye